jobs.jnj.com/en/jobs/
Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Share
Did you like reading this story? Click the heart to show your love.
Empty Heart Icon
59
Latest News

What You Need to Know About Johnson & Johnson's 2022 Third-Quarter Earnings

Share
Did you like reading this story? Click the heart to show your love.
Empty Heart Icon
59
Check out this infographic breakdown of the company’s third-quarter 2022 performance, with key highlights from its Pharmaceutical, MedTech and Consumer Health businesses.
Today's Top Reads Close
Share
Did you like reading this story? Click the heart to show your love.
Empty Heart Icon
59
expand

This morning, Johnson & Johnson shared its third-quarter performance.

Since its founding in 1886, the company has grown to become one of the world's largest and most broadly based healthcare companies, with approximately 144,000 employees across the globe working every day to help change the trajectory of health for humanity.

“The solid results delivered this quarter, including accelerated operational sales* growth in all three of our segments, reflect the strength of our business, versatility of our operations, and the unwavering commitment of Johnson & Johnson’s employees to patients and consumers around the world," says Joe Wolk Circular image Joe Wolk,Executive Vice President and Chief Financial Officer, Johnson & Johnson, Executive Vice President and Chief Financial Officer, Johnson & Johnson. "We invested in R&D at increased levels, advanced our pipeline and returned significant value to shareholders. Looking ahead, we will continue to execute against our long-term strategy, focused on improving health outcomes and access to care.”

For more details about the company's 2022 third-quarter results, and to read a message from Chief Executive Officer Joaquin Duato Circular image Joaquin DuatoChief Executive Officer, Johnson & Johnson, here's an infographic that highlights key stats.

*Non-GAAP financial measure. Refer to the reconciliations in the full press release.


Share
Did you like reading this story? Click the heart to show your love.
Empty Heart Icon
59
expand

Read the earnings press release, which includes full financial data for the third quarter of 2022.

Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.

Did you like reading this story? Click the heart to show your love.
Empty Heart Icon
59

More from Johnson & Johnson

This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
Close cookie banner icon
Back to top
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue